Release Date: 22/06/17 17:47 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document Not available as of the moment. Download
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial